Outshine the giants: these 28 early-stage AI stocks could fund your retirement.
To own Alexandria Real Estate Equities, you need to be comfortable with a life science REIT that is currently unprofitable, facing weaker leasing conditions and pressure on same‑property NOI, but still investing behind its lab‑focused footprint. The new US$750,000,000 5.25% notes and tender offers look more like a balance sheet clean‑up than a catalyst, with limited direct impact on nearer term drivers such as leasing velocity and vacancy or on the key risk of earnings pressure from elevated impairments and lower margins.
The refinancing ties directly into the recent tender offers for the 2050, 2051 and 2052 notes, where Alexandria increased the Aggregate Maximum Tender Amount to absorb all bonds tendered by the early deadline. In my view, this move is most relevant because it sits alongside a tough 2025 result, with a US$1,717,200,000 impairment and a US$1,429,570,000 annual net loss, underlining how balance sheet decisions now sit against a backdrop of weaker profitability and asset valuations.
Yet, against this refinancing effort, investors should still pay close attention to the ongoing securities lawsuit and what it may reveal about...
Read the full narrative on Alexandria Real Estate Equities (it's free!)
Alexandria Real Estate Equities’ narrative projects $3.2 billion revenue and $288.1 million earnings by 2028.
Uncover how Alexandria Real Estate Equities' forecasts yield a $57.46 fair value, a 9% upside to its current price.
Some of the most optimistic analysts saw Alexandria reaching about US$3.2 billion of revenue and US$435 million of earnings by 2028, far above consensus, and viewed today’s refinancing differently from the risk that large, ongoing capital needs and reliance on asset sales could still pressure earnings and asset values if conditions stay tough.
Explore 9 other fair value estimates on Alexandria Real Estate Equities - why the stock might be worth over 2x more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com